ARTICLE
|
doi:10.20944/preprints202405.0782.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
Pancreatic cancer; pancreatic ductal adenocarcinoma; gemcitabine; growth hormone (GH); GH receptor (GHR); GHR antagonist; insulin-like growth factor 1 (IGF1); adjuvant; chemotherapy; chemoresistance
Online: 13 May 2024 (12:30:24 CEST)